Modernas stock price (MRNA) inched higher in latest intraday trading, attacking the current resistance level of $31.12 amid the dominance of an upward correctional wave in the short term, supported by trading above the 50-day SMA and positive signals streaming from the Stochastic, despite it reaching extremely overbought levels.

Therefore we expect the stock to rise in upcoming trading, provided it first breaches the aforementioned resistance of $31.12, targeting the next one at $36.75.

Todays price forecast: Bullish